Genetesis
Mason, United States · $34.2M raised
- Headquarters
- Mason, Ohio
- Business Model
- B2B
- Website
- genetesis.com
- Total Funding
- $34.2M
- Last Round
- $17.5M Series COct 2022
- Rounds
- 3
About
Genetesis developed the CardioFlux MCG cardiac diagnostic imaging system; sold its MCG assets to a strategic buyer in Summer 2025.
Summary
Genetesis is a Healthcare company based in Mason, United States. It has raised $34.2M in total across 3 rounds, most recently a $17.5M Series C round in Oct 2022. Investors include Mark Cuban, Mithril Capital and TDK Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...